WT1 and neoplasm: Potential for clinical trials in humans to evaluate the effectiveness of WT1-targetedtherapies (60)Checkpoint inhibitors combined with WT1-specific T cells enhance tumor targeting by boosting immune response and preventing immune suppression (60)